Molecular Templates (MTEM)
(Delayed Data from NSDQ)
$1.71 USD
+0.11 (6.56%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $1.74 +0.04 (2.05%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Price, Consensus and EPS Surprise
MTEM 1.71 +0.11(6.56%)
Will MTEM be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MTEM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MTEM
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Molecular Templates Inc. (MTEM)
Will Molecular Templates Inc. (MTEM) Report Negative Q1 Earnings? What You Should Know
MTEM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Molecular Templates Inc. (MTEM) Reports Q4 Loss, Lags Revenue Estimates
Adherex Technologies Inc. (FENC) Reports Q4 Loss, Lags Revenue Estimates
Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates
Other News for MTEM
Molecular Templates files to sell 11.01M common shares for holders
Molecular Templates files to sell 11.01M shares of common stock for holders
Molecular Templates Inc Announces Layoffs, CMO Resignation
MTEM Stock Earnings: Molecular Templates Beats EPS, Misses Revenue for Q4 2023
Biotech Alert: Searches spiking for these stocks today